Transplants force patients to amass vaccinations to beat COVID
Transplants force patients to amass vaccinations to beat COVID
BLOOMBERG
Syringes with doses of the Moderna Inc. COVID-19 vaccine.
For Cleveland Heights resident Jennifer Woda, two doses of the Moderna Inc. vaccine were not enough protection against the COVID-19 virus. Over a month later, she got a third and fourth dose, this time with the Pfizer Inc.-BioNTech SE vaccine.
An opera singer who teaches music to kids, Woda received a kidney transplant in September 2019, one of about 160,000 transplants that have occurred in the U.S. since 2017. Emerging research is now showing that these patients, who suppress their immune system with drugs so their bodies don t reject donated organs, are dramatically less likely to develop protective antibodies using the authorized vaccine dosage.